My Portfolio

Benchmarks

India-specific valuation benchmarks by stage and sector. Based on closed deals and platform data.

Seed Stage — India Benchmarks (2025–2026)

Median Valuation

₹8–15Cr

Valuation Range

₹5–30Cr

Revenue Multiple

15–25× ARR

Typical Check

₹50L–₹2Cr

Typical equity: 10–20%

MVP or early revenue. Growing traction is the key signal.

Sector Revenue Multiples — India (Seed Stage)

ARR multiples for Indian startups at Seed. Based on closed deal data and IVL platform signals.

Sector

ARR Multiple

Note

Seed Valuation

SaaS / Enterprise

10–20×

NRR > 120% commands premium

₹10–20Cr

FinTech

8–15×

Regulated plays trade at discount

₹8–15Cr

D2C / Consumer

4–8×

Revenue multiples; D2C compressed

₹5–12Cr

HealthTech

6–12×

Clinical validation adds premium

₹6–12Cr

DeepTech / AI

15–30×

IP and team-driven premium

₹15–40Cr

AgriTech

4–8×

Impact premium partially offsets margin compression

₹5–10Cr

EdTech

5–10×

Post-2021 correction; B2B > B2C

₹5–10Cr

CleanTech

8–15×

Hardware/asset-heavy at discount; software at premium

₹8–20Cr

LogiTech

5–10×

Marketplace model preferred

₹6–12Cr

IVL Platform — Top Rated Startups Right Now

#1

Max Healthcare

HealthTech

81/100

#2

BookMyShow

Event Tech

75/100

#3

Flipkart

E-Commerce

74/100

#4

Cars24

Marketplace

72/100

#5

Krsnaa Diagnostics

HealthTech

71/100